IGM Biosciences
(NASDAQ:IGMS)
$9.36
1.71[22.35%]
At close: Apr 26
$9.36
0[0.00%]
After Hours: 4:52PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

IGM Biosciences Stock (NASDAQ:IGMS), Quotes and News Summary

IGM Biosciences Stock (NASDAQ: IGMS) stock price, news, charts, stock research, profile.

Open$7.740
Close$9.400
Volume / Avg.468.943K / 274.734K
Day Range7.410 - 9.480
52 Wk Range3.810 - 17.700
Market Cap$550.242M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest
33.52%
Days to Cover20.91

Recent News

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1.
Avi Kapoor
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply in today’s pre-market trading.
Avi Kapoor
RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its potential in lupus and rheumatoid arthritis.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
1
Nov 23
2
Dec 23
1
Feb
2
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About IGM Biosciences Inc
Sector
Health Care
Industry
Biotechnology
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeuti...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IGMS
HUMA

FAQ

Q

How do I buy IGM Biosciences (IGMS) stock?

A

You can purchase shares of IGM Biosciences (NASDAQ: IGMS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are IGM Biosciences's (IGMS) competitors?

A

Other companies in IGM Biosciences’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Voyager Therapeutics (NASDAQ:VYGR) and Larimar Therapeutics (NASDAQ:LRMR).

Q

What is the target price for IGM Biosciences (IGMS) stock?

A

The latest price target for IGM Biosciences (NASDAQ: IGMS) was reported by HC Wainwright & Co. on Thursday, April 18, 2024. The analyst firm set a price target for 12.00 expecting IGMS to rise to within 12 months (a possible 28.21% upside). 22 analyst firms have reported ratings in the last year.

Q

Current Stock Price for IGM Biosciences (IGMS)?

A

The stock price for IGM Biosciences (NASDAQ: IGMS) is $9.36 last updated April 26, 2024 at 4:52 PM EDT.

Q

Does IGM Biosciences (IGMS) pay a dividend?

A

There are no upcoming dividends for IGM Biosciences.

Q

When is IGM Biosciences (NASDAQ:IGMS) reporting earnings?

A

IGM Biosciences’s Q1 earnings are confirmed for Friday, May 10, 2024.

Q

Is IGM Biosciences (IGMS) going to split?

A

There is no upcoming split for IGM Biosciences.

Q

What sector and industry does IGM Biosciences (IGMS) operate in?

A

IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch